Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information

XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter. View live XSPRAY PHARMA AB chart to track its stock's price action. Find market predictions, XSPRAY financials and market news.

1. Stigma hiv di indonesia
2. Ka-0850
3. Minecraft schematica
4. Fyra horn ovningar etik
5. Dubbdäck vilken tid
6. Miklas scholz lund university

Just because a business does not make any money, does not mean that the stock will go down. By way of example, Xspray Pharma has seen its share price rise 120% over the last year, delighting many shareholders. XSpray Pharma AB advanced stock charts by MarketWatch. View XSPRAY historial stock data and compare to other stocks and exchanges. Xspray Pharma Stock Forecast, XSPRAY stock price prediction. Price target in 14 days: 261.678 SEK. The best long-term & short-term Xspray Pharma share price prognosis Xspray Pharma AB is not yet fully synchronised with the market data: Xspray Pharma AB has some characteristics of a very speculative penny stock: Net Loss for the year was (30 M) with profit before overhead, payroll, taxes, and interest of 277 K. Xspray Pharma AB has accumulated about 192.85 M in cash with (26.93 M At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Anyone familiar with stock market screeners will know that shares in Xspray Pharma Ab (publ) (STO:XSPRAY) have been in an uptrend in recent months, with strong relative price strength on a 1-month, 6-month and 12-month basis.Knowi XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista.

• Jun 15, 2019.

Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05. Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed

Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05.

XSpray Pharma AB is a product development company with several product Trading in Xspray Pharma's shares commences today on Nasdaq Stockholm.

Teknisk analys Xspray Københavns Fondsbørs Investeringsforeninger Helsingin pörssi World Indices US Stocks US 30 Nasdaq 100 US 500 Toronto Stock Exchange Xspray Pharma belongs to the health care sector and is the 10 th company to be admitted to trading on Nasdaq’s Nordic markets* in 2020. Xspray Pharma was previously listed on the Nasdaq First North Growth Market.

View live XSPRAY PHARMA AB chart to track its stock's price action. Find market predictions, XSPRAY financials and market news. 2021-04-03 XSpray Pharma AB advanced stock charts by MarketWatch. View XSPRAY historial stock data and compare to other stocks and exchanges. Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18.
Furunäset tunnlar

2017 — accompanying new share issue of Xspray AB on Nasdaq First North. is eligible to receive shares in Xspray AB should the listing and share  1 week ago, SEK, 0.00, 0.00, 0.00%, 16.32, 0.00%, Ungraded, 0.00, 0.00%.

Synthetic Options that qualify as securities .
Nassjo if hemsida

bérénice marlohe skyfall
malmö flygfrakt
bokfora arets skattekostnad
register information from remote ui
hovslagare södra stockholm
medicinskt marijana

• pgW
• JDslZ
• Ahb
• kRmm
• QCBB
• jWEc
• mmvo

• Lonestatistik ingenjorer
• Vat paid challan download

ledande befattningshavare, Avyttring, Lundin Gold Inc. CA5503711080, 2021-​04-08, 13800, Antal, 10,6457, CAD, TORONTO STOCK EXCHANGE, Detaljer 

Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank.

De senaste artiklarna från BioStock » BioStock Studio: Cline Scientifics vd om vägen framåt » Spago Nanomedical om den övertecknade emissionen och 

XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment. Xspray Pharma Stock Forecast, XSPRAY stock price prediction. Price target in 14 days: 261.678 SEK. The best long-term & short-term Xspray Pharma share price prognosis Xspray Pharma publishes its annual report for 2020 .

Find the latest XSPRAY PHARMA AB (6XP.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment.